Press Release10 May 2024, 07:37 pm
Dr. Lal PathLabs Ltd Announces 50.8% Increase in PAT for Q4 FY24
AI Summary
Dr. Lal PathLabs Ltd, a leading diagnostic and healthcare service provider, has announced its financial results for the quarter ended March 31, 2024. The company reported an 11.1% increase in revenue, a 25.1% increase in EBITDA, and a 50.8% increase in PAT. The EBITDA margin stood at 26.5% and the PAT margin was 15.7%.
Key Highlights
- Revenue increased by 11.1% in Q4 FY24
- EBITDA increased by 25.1% with a margin of 26.5%
- PAT increased by 50.8% with a margin of 15.7%